{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:03:24Z","timestamp":1786982604504,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Ministry of Education, Culture, Sports, Science and Technolog"},{"DOI":"10.13039\/501100013170","name":"Ono Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s13300-021-01008-y","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T19:13:40Z","timestamp":1613589220000},"page":"827-842","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Glucose Variability is Independently Correlated with Serum Level of Pigment Epithelium-Derived Factor in Type 2 Diabetes"],"prefix":"10.1007","volume":"12","author":[{"given":"Tomoki","family":"Fujikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6137-5493","authenticated-orcid":false,"given":"Makoto","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo","family":"Kohata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroe","family":"Nagaike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Fukase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Osaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Yashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Shinmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munenori","family":"Hiromura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michishige","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusaku","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho-ichi","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,13]]},"reference":[{"key":"1008_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0014-4835(91)90248-D","volume":"53","author":"J Tombran-Tink","year":"2019","unstructured":"Tombran-Tink J, Chader GG, Johnson LV. PEDF: pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res. 2019;53:411\u20134.","journal-title":"Exp Eye Res"},{"key":"1008_CR2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrn1176","volume":"4","author":"J Tombran-Tink","year":"2003","unstructured":"Tombran-Tink J, Barnstable CJ. PEDF: a multifaceted neurotrophic factor. Nat Rev Neurosci. 2003;4:628\u201336.","journal-title":"Nat Rev Neurosci"},{"key":"1008_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1126\/science.285.5425.245","volume":"285","author":"DW Dawson","year":"1999","unstructured":"Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 1999;285:245\u20138.","journal-title":"Science"},{"key":"1008_CR4","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2174\/138945008786786154","volume":"9","author":"S Yamagishi","year":"2008","unstructured":"Yamagishi S, Matsui T, Nakamura K, Ueda S, Noda Y, Imaizumi T. Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications. Curr Drug Targets. 2008;9:1025\u20139.","journal-title":"Curr Drug Targets"},{"key":"1008_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2174\/1381612825666190319112106","volume":"25","author":"SI Yamagishi","year":"2019","unstructured":"Yamagishi SI, Koga Y, Sotokawauchi A, et al. Therapeutic potential of pigment epithelium-derived factor in cancer. Curr Pharm Des. 2019;25:313\u201324.","journal-title":"Curr Pharm Des"},{"key":"1008_CR6","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/ijo.2010.212","volume":"35","author":"S Famulla","year":"2011","unstructured":"Famulla S, Lamers D, Hartwig S, et al. Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells. Int J Obes. 2011;35:762\u201372.","journal-title":"Int J Obes"},{"key":"1008_CR7","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.2174\/0929867324666170608103140","volume":"25","author":"SI Yamagishi","year":"2018","unstructured":"Yamagishi SI, Matsui T. Pigment epithelium-derived factor: a novel therapeutic target for cardiometabolic diseases and related complications. Curr Med Chem. 2018;25:1480\u2013500.","journal-title":"Curr Med Chem"},{"key":"1008_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2174\/156652410791065264","volume":"10","author":"SI Yamagishi","year":"2010","unstructured":"Yamagishi SI, Matsui T. Anti-atherothrombogenic properties of PEDF. Curr Mol Med. 2010;10:284\u201391.","journal-title":"Curr Mol Med"},{"key":"1008_CR9","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1080\/10715762.2019.1697809","volume":"53","author":"N Brook","year":"2019","unstructured":"Brook N, Brook E, Dharmarajan A, Chan A, Dass CR. The role of pigment epithelium-derived factor in protecting against cellular stress. Free Radic Res. 2019;53:1166\u201380.","journal-title":"Free Radic Res"},{"key":"1008_CR10","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/jc.2005-2654","volume":"91","author":"S Yamagishi","year":"2006","unstructured":"Yamagishi S, Adachi H, Abe A, et al. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab. 2006;91:2447\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"1008_CR11","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.diabres.2008.06.019","volume":"82","author":"A Jenkins","year":"2008","unstructured":"Jenkins A, Zhang SX, Gosmanova A, et al. Increased serum pigment epithelium derived factor levels in type 2 diabetes patients. Diabetes Res Clin Pract. 2008;82:e5-7.","journal-title":"Diabetes Res Clin Pract"},{"key":"1008_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/dmrr.820","volume":"25","author":"K Nakamura","year":"2009","unstructured":"Nakamura K, Yamagishi S, Adachi H, Kurita-Nakamura Y, Matsui T, Inoue H. Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes. Diabetes Metab Res Rev. 2009;25:52\u20136.","journal-title":"Diabetes Metab Res Rev"},{"key":"1008_CR13","first-page":"346938","volume":"2015","author":"TH Li","year":"2015","unstructured":"Li TH, Qiu CJ, Yu XJ, Liu DD, Zhou PF, Wu L. Increased serum pigment epithelium-derived factor in women with gestational diabetes is associated with type 2 diabetes. Int J Endocrinol. 2015;2015:346938.","journal-title":"Int J Endocrinol"},{"key":"1008_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cmet.2009.06.001","volume":"10","author":"S Crowe","year":"2009","unstructured":"Crowe S, Wu LE, Economou C, et al. A hyperinsulinemic\u2013euglycemic clamp study. Cell Metab. 2009;10:40\u20137.","journal-title":"Cell Metab"},{"key":"1008_CR15","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.jdiacomp.2017.06.002","volume":"31","author":"FJK Toloza","year":"2017","unstructured":"Toloza FJK, P\u00e9rez-Matos MC, Ricardo-Silgado ML, et al. Comparison of plasma pigment epithelium-derived factor (PEDF), retinol binding protein 4 (RBP-4), chitinase-3-like protein 1 (YKL-40) and brain-derived neurotrophic factor (BDNF) for the identification of insulin resistance. J Diabetes Complicat. 2017;31:1423\u20139.","journal-title":"J Diabetes Complicat"},{"key":"1008_CR16","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/oby.2012.135","volume":"20","author":"AE Joham","year":"2012","unstructured":"Joham AE, Teede HJ, Hutchison SK, et al. Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: impact of exercise training. Obesity (Silver Spring). 2012;20:2390\u20136.","journal-title":"Obesity (Silver Spring)"},{"key":"1008_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.autneu.2005.05.006","volume":"121","author":"BL Lashbrook","year":"2005","unstructured":"Lashbrook BL, Steinle JJ. Beta-adrenergic receptor regulation of pigment epithelial-derived factor expression in rat retina. Auton Neurosci. 2005;121:33\u20139.","journal-title":"Auton Neurosci"},{"key":"1008_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ijcard.2008.04.055","volume":"136","author":"K Nakamura","year":"2009","unstructured":"Nakamura K, Yamagishi S, Adachi H, et al. Serum level of pigment epithelium derived factor (PEDF) is an independent determinant of resting heart rate in Japanese subjects. Int J Cardiol. 2009;136:245\u20137.","journal-title":"Int J Cardiol"},{"key":"1008_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.atherosclerosis.2011.06.022","volume":"219","author":"N Tahara","year":"2011","unstructured":"Tahara N, Yamagishi SI, Tahara A, et al. Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans. Atherosclerosis. 2011;219:311\u20135.","journal-title":"Atherosclerosis"},{"key":"1008_CR20","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.2169\/internalmedicine.50.5460","volume":"50","author":"A Iwata","year":"2011","unstructured":"Iwata A, Miura S, Morii J, Yamagishi SI, Saku K. Association between plasma pigment epithelium-derived factor levels and tissue characteristics of coronary plaque using integrated backscatter intravascular ultrasound. Intern Med. 2011;50:1889\u201394.","journal-title":"Intern Med"},{"key":"1008_CR21","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1177\/147323001103900322","volume":"39","author":"Y Shiga","year":"2011","unstructured":"Shiga Y, Miura S, Mitsutake R, Yamagishi S, Saku K. Significance of plasma levels of pigment epithelium-derived factor as determined by multidetector row computed tomography in patients with mild chronic kidney disease and\/or coronary artery disease. J Int Med Res. 2011;39:880\u201390.","journal-title":"J Int Med Res"},{"key":"1008_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12325-019-0870-x","volume":"36","author":"R Ajjan","year":"2019","unstructured":"Ajjan R, Slattery D, Wright E. Continuous glucose monitoring: a brief review for primary care practitioners. Adv Ther. 2019;36:579\u201396.","journal-title":"Adv Ther"},{"key":"1008_CR23","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s13300-019-0619-1","volume":"10","author":"H Chehregosha","year":"2019","unstructured":"Chehregosha H, Khamseh ME, Malek M, Hosseinpanah F, Ismail-Beigi F. A view beyond HbA1c: role of continuous glucose monitoring. Diabetes Ther. 2019;10:853\u201363.","journal-title":"Diabetes Ther"},{"key":"1008_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.diabres.2016.09.025","volume":"122","author":"M Ohara","year":"2016","unstructured":"Ohara M, Fukui T, Ouchi M, et al. Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes. Diabetes Res Clin Pract. 2016;122:62\u201370.","journal-title":"Diabetes Res Clin Pract"},{"key":"1008_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatine. Nephron. 1976;16:31\u201341.","journal-title":"Nephron"},{"key":"1008_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/jdi.12600","volume":"8","author":"E Araki","year":"2017","unstructured":"Araki E, Haneda M, Kasuga M, et al. New glycemic targets for patients with diabetes from the Japan Diabetes Society. J Diabetes Investig. 2017;8:123\u20135.","journal-title":"J Diabetes Investig"},{"key":"1008_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/193229681100500236","volume":"5","author":"D Czerwoniuk","year":"2011","unstructured":"Czerwoniuk D, Fendler W, Walenciak L, Mlynarski W. GlyCulator: a glycemic variability calculation tool for continuous glucose monitoring data. J Diabetes Sci Technol. 2011;5:447\u201351.","journal-title":"J Diabetes Sci Technol"},{"key":"1008_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.diabres.2018.02.017","volume":"139","author":"M Ohara","year":"2018","unstructured":"Ohara M, Nagaike H, Goto S, et al. Improvements of ambient hyperglycemia and glycemic variability are associated with reduction in oxidative stress for patients with type 2 diabetes. Diabetes Res Clin Pract. 2018;139:253\u201361.","journal-title":"Diabetes Res Clin Pract"},{"key":"1008_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2174\/156652410791065318","volume":"10","author":"K Fukami","year":"2010","unstructured":"Fukami K, Yamagishi S, Okuda S. Development of enzyme-linked immunosorbent assay system for PEDF and its clinical utility. Curr Mol Med. 2010;10:317\u201320.","journal-title":"Curr Mol Med"},{"key":"1008_CR30","doi-asserted-by":"publisher","first-page":"e0197663","DOI":"10.1371\/journal.pone.0197663","volume":"13","author":"T Okura","year":"2018","unstructured":"Okura T, Nakamura R, Fujioka Y, et al. CPR-IR is an insulin resistance index that is minimally affected by hepatic insulin clearance\u2014a preliminary research. PLoS One. 2018;13:e0197663.","journal-title":"PLoS One"},{"key":"1008_CR31","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s13300-020-00772-7","volume":"11","author":"Y Kohata","year":"2020","unstructured":"Kohata Y, Ohara M, Nagaike H, et al. Association of hemoglobin A1c, 1,5-anhydro-d-glucitol and glycated albumin with oxidative stress in type 2 diabetes mellitus patients: a cross-sectional study. Diabetes Ther. 2020;11:655\u201365.","journal-title":"Diabetes Ther"},{"key":"1008_CR32","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/dme.12198","volume":"30","author":"S Pek","year":"2013","unstructured":"Pek S, Tavintharan S, Woon K, Niyati J, Lim SC, Sum CF. Associations between pigment epithelium-derived factor, insulin resistance and high density lipoprotein. Diabet Med. 2013;30:1067\u201374.","journal-title":"Diabet Med"},{"key":"1008_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.5603\/CJ.2011.0006","volume":"18","author":"T Arimura","year":"2011","unstructured":"Arimura T, Miura S, Sugihara M, Iwata A, Yamagishi S, Saku K, Cardiol J. Association between plasma levels of pigment epithelium-derived factor and renal dysfunction in patients with coronary artery disease. Cardiol J. 2011;18:515\u201320.","journal-title":"Cardiol J"},{"key":"1008_CR34","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1373\/clinchem.2006.073171","volume":"52","author":"Y Motomiya","year":"2006","unstructured":"Motomiya Y, Yamagishi S, Adachi H, Abe A. Increased serum concentrations of pigment epithelium-derived factor in patients with end-stage renal disease. Clin Chem. 2006;52:1970\u20131.","journal-title":"Clin Chem"},{"key":"1008_CR35","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1111\/j.1464-5491.2007.02281.x","volume":"24","author":"AJ Jenkins","year":"2007","unstructured":"Jenkins AJ, Zhang SX, Rowley KG, et al. Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes. Diabet Med. 2007;24:1345\u201351.","journal-title":"Diabet Med"},{"key":"1008_CR36","doi-asserted-by":"publisher","first-page":"E2169","DOI":"10.1210\/jc.2014-2235","volume":"99","author":"E Hui","year":"2014","unstructured":"Hui E, Yeung CY, Lee PC, et al. Elevated circulating pigment epithelium-derived factor predicts the progression of diabetic nephropathy in patients with type 2 diabetes. J Clin Endocrinol Metab. 2014;99:E2169\u20132177.","journal-title":"J Clin Endocrinol Metab"},{"key":"1008_CR37","doi-asserted-by":"publisher","first-page":"E739","DOI":"10.1210\/jc.2014-3896","volume":"100","author":"N Tahara","year":"2015","unstructured":"Tahara N, Yamagishi S, Kodama N, et al. Clinical and biochemical factors associated with area and metabolic activity in the visceral and subcutaneous adipose tissues by FDG-PET\/CT. J Clin Endocrinol Metab. 2015;100:E739\u2013747.","journal-title":"J Clin Endocrinol Metab"},{"key":"1008_CR38","doi-asserted-by":"publisher","first-page":"107410","DOI":"10.1016\/j.jdiacomp.2019.107410","volume":"33","author":"KJ Hunt","year":"2019","unstructured":"Hunt KJ, Jenkins AJ, Fu D, et al. Serum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort. J Diabetes Complications. 2019;33:107410.","journal-title":"J Diabetes Complications"},{"issue":"43","key":"1008_CR39","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.2337\/dc20-S007","volume":"2020","author":"American Diabetes Association","year":"2020","unstructured":"American Diabetes Association. 7. Diabetes technology: standards of medical care in diabetes-2020. Diabetes Care. 2020;2020(43):S77\u201388.","journal-title":"Diabetes Care"},{"key":"1008_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1475-2840-10-19","volume":"10","author":"G Su","year":"2011","unstructured":"Su G, Mi S, Tao H, et al. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol. 2011;10:19.","journal-title":"Cardiovasc Diabetol"},{"key":"1008_CR41","first-page":"38","volume":"125","author":"SH Mi","year":"2012","unstructured":"Mi SH, Su G, Li Z, et al. Comparison of glycemic variability and glycated hemoglobin as risk factors of coronary artery disease in patients with undiagnosed diabetes. Chin Med J (Engl). 2012;125:38\u201343.","journal-title":"Chin Med J (Engl)"},{"key":"1008_CR42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1758-5996-6-76","volume":"6","author":"JW Zhang","year":"2014","unstructured":"Zhang JW, He LJ, Cao SJ, Yang Q, Yang SW, Zhou YJ. Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions. Diabetol Metab Syndr. 2014;6:76.","journal-title":"Diabetol Metab Syndr"},{"key":"1008_CR43","doi-asserted-by":"publisher","first-page":"e10860","DOI":"10.1097\/MD.0000000000010860","volume":"97","author":"L Tong","year":"2018","unstructured":"Tong L, Chi C, Zhang Z. Association of various glycemic variability indices and vascular outcomes in type-2 diabetes patients: a retrospective study. Medicine (Baltimore). 2018;97:e10860.","journal-title":"Medicine (Baltimore)"},{"key":"1008_CR44","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.diabet.2019.01.012","volume":"45","author":"M Benalia","year":"2019","unstructured":"Benalia M, Zeller M, Mouhat B, et al. Glycaemic variability is associated with severity of coronary artery disease in patients with poorly controlled type 2 diabetes and acute myocardial infarction. Diabetes Metab. 2019;45:446\u201352.","journal-title":"Diabetes Metab"},{"key":"1008_CR45","doi-asserted-by":"publisher","first-page":"316","DOI":"10.2337\/dc14-0920","volume":"38","author":"K Khunti","year":"2015","unstructured":"Khunti K, Davies M, Majeed A, et al. Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes Care. 2015;38:316\u201322.","journal-title":"Diabetes Care"},{"key":"1008_CR46","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/jdi.12750","volume":"9","author":"N Otowa-Suematsu","year":"2017","unstructured":"Otowa-Suematsu N, Sakaguchi K, Komada H, et al. Comparison of the relationship between multiple parameters of glycemic variability and coronary plaque vulnerability assessed by virtual histology-intravascular ultrasound. J Diabetes Investig. 2017;9:610\u20135.","journal-title":"J Diabetes Investig"},{"key":"1008_CR47","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijcard.2013.12.289","volume":"172","author":"N Tahara","year":"2014","unstructured":"Tahara N, Matsui T, Yamagishi S. Change in serum PEDF level after pioglitazone treatment is independently correlated with that in HOMA-IR. Int J Cardiol. 2014;172:244\u20136.","journal-title":"Int J Cardiol"},{"key":"1008_CR48","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.2337\/diabetes.52.11.2795","volume":"52","author":"L Quagliaro","year":"2003","unstructured":"Quagliaro L, Piconi L, Assaloni R, et al. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes. 2003;52:2795\u2013804.","journal-title":"Diabetes"},{"key":"1008_CR49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/dmrr.962","volume":"25","author":"L Monnier","year":"2009","unstructured":"Monnier L, Colette C, Owens DR. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept. Diabetes Metab Res Rev. 2009;25:393\u2013402.","journal-title":"Diabetes Metab Res Rev"},{"key":"1008_CR50","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.2337\/dc07-0817","volume":"30","author":"JB Meigs","year":"2007","unstructured":"Meigs JB, Larson MG, Fox CS, et al. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study. Diabetes Care. 2007;30:2529\u201335.","journal-title":"Diabetes Care"},{"key":"1008_CR51","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12944-018-0889-z","volume":"17","author":"S Ma","year":"2018","unstructured":"Ma S, Wang S, Li M, Zhang Y, Zhu P. The effects of pigment epithelium-derived factor on atherosclerosis: putative mechanisms of the process. Lipids Health Dis. 2018;17:240.","journal-title":"Lipids Health Dis"},{"key":"1008_CR52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1475-2840-12-56","volume":"12","author":"F Wang","year":"2013","unstructured":"Wang F, Ma X, Zhou M, et al. Serum pigment epithelium-derived factor levels are independently correlated with the presence of coronary artery disease. Cardiovasc Diabetol. 2013;12:56.","journal-title":"Cardiovasc Diabetol"},{"key":"1008_CR53","first-page":"137","volume":"2","author":"AW Gardner","year":"2015","unstructured":"Gardner AW, Parker DE, Montgomery PS, et al. Influence of diabetes on ambulation and inflammation in men and women with symptomatic peripheral artery disease. J Clin Transl Endocrinol. 2015;2:137\u201343.","journal-title":"J Clin Transl Endocrinol"},{"key":"1008_CR54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/MCA.0000000000000192","volume":"26","author":"T Nozue","year":"2015","unstructured":"Nozue T, Yamagishi S, Hirano T, et al. Pigment epithelium-derived factor is associated with necrotic core progression during statin therapy. Coron Artery Dis. 2015;26:107\u201313.","journal-title":"Coron Artery Dis"},{"key":"1008_CR55","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2174\/13816128113199990479","volume":"20","author":"N Tahara","year":"2014","unstructured":"Tahara N, Tahara A, Honda A, et al. Molecular imaging of vascular inflammation. Curr Pharm Des. 2014;20:2439\u201347.","journal-title":"Curr Pharm Des"},{"key":"1008_CR56","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.ajpath.2013.12.032","volume":"184","author":"T Matsui","year":"2014","unstructured":"Matsui T, Nishino Y, Ojima A, Maeda S, Tahara N, Yamagishi SI. Pigment epithelium-derived factor improves metabolic derangements and ameliorates dysregulation of adipocytokines in obese type 2 diabetic rats. Am J Pathol. 2014;184:1094\u2013103.","journal-title":"Am J Pathol"},{"key":"1008_CR57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1177\/147323000703500319","volume":"35","author":"K Nakamura","year":"2007","unstructured":"Nakamura K, Yamagishi S, Yoshida T, et al. Hydrogen peroxide stimulates pigment epithelium-derived factor gene and protein expression in the human hepatocyte cell line OUMS-29. J Int Med Res. 2007;35:427\u201332.","journal-title":"J Int Med Res"},{"key":"1008_CR58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.phrs.2009.07.003","volume":"61","author":"S Yamagishi","year":"2010","unstructured":"Yamagishi S, Matsui T, Adachi H, Takeuchi M. Positive association of circulating levels of advanced glycation end products (AGEs) with pigment epithelium-derived factor (PEDF) in a general population. Pharmacol Res. 2010;61:103\u20137.","journal-title":"Pharmacol Res"},{"key":"1008_CR59","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1210\/jc.2018-01833","volume":"104","author":"F Biobaku","year":"2019","unstructured":"Biobaku F, Ghanim H, Batra M, Dandona P. Macronutrient-mediated inflammation and oxidative stress: relevance to insulin resistance, obesity, and atherogenesis. J Clin Endocrinol Metab. 2019;104:6118\u201328.","journal-title":"J Clin Endocrinol Metab"},{"key":"1008_CR60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4161\/oxim.3.2.11148","volume":"3","author":"S Yamagishi","year":"2010","unstructured":"Yamagishi S, Matsui T. Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med Cell Longev. 2010;3:101\u20138.","journal-title":"Oxid Med Cell Longev"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01008-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-021-01008-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01008-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:18:05Z","timestamp":1650241085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-021-01008-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,13]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1008"],"URL":"https:\/\/doi.org\/10.1007\/s13300-021-01008-y","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,13]]},"assertion":[{"value":"12 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}